Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:50 PM
Ignite Modification Date:
2025-12-24 @ 4:50 PM
NCT ID:
NCT01018550
Eligibility Criteria:
Inclusion Criteria:
* Males or females 18 to 65 years of age
* Percent of predicted FEV1 ≥ 50% and ≤ 80%
* At least 12% reversibility over pre-bronchodilator FEV1
* Inhaled corticosteroid (ICS) ≥ 200 and ≤ 1000 µg/day fluticasone or equivalent.
* Ongoing asthma symptoms with ACQ score ≥ 1.5 points
Exclusion Criteria:
* History of chronic obstructive pulmonary disease or other chronic pulmonary condition other than asthma
* Any uncontrolled, clinically significant systemic disease
* Respiratory infection within 4 weeks of the screening visit
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT01018550
Study Brief:
Protocol Section:
NCT01018550